Determination of dopamine concentrations in brain extracellular fluid using microdialysis with short sampling intervals, analyzed by ultra high performance liquid chromatography tandem mass spectrometry
Tóm tắt
Từ khóa
Tài liệu tham khảo
Berg, 2011, C-13 labelled internal standards—A solution to minimize ion suppression effects in liquid chromatography–tandem mass spectrometry analyses of drugs in biological samples?, Journal of Chromatography A, 1218, 9366, 10.1016/j.chroma.2011.10.081
Bicker, 2013, Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples — A review, Analytica Chimica Acta, 768, 12, 10.1016/j.aca.2012.12.030
Cannazza, 2012, Simultaneous measurement of adenosine, dopamine, acetylcholine and 5-hydroxytryptamine in cerebral mice microdialysis samples by LC–ESI–MS/MS, Journal of Pharmaceutical and Biomedical Analysis, 71, 183, 10.1016/j.jpba.2012.08.004
Couchman, 2011, LC–MS in analytical toxicology: Some practical considerations, Biomedical Chromatography, 25, 100, 10.1002/bmc.1566
Gottas, 2014, Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin, International Journal of Neuropsychopharmacology, 17, 1357, 10.1017/S1461145714000169
Gottas, 2012, Simultaneous measurement of heroin and its metabolites in brain extracellular fluid by microdialysis and ultra performance liquid chromatography tandem mass spectrometry, Journal of Pharmacological and Toxicological Methods, 66, 14, 10.1016/j.vascn.2012.04.009
Gottas, 2013, Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats, British Journal of Pharmacology, 170, 546, 10.1111/bph.12305
Greco, 2013, Microdialysate analysis of monoamine neurotransmitters—A versatile and sensitive LC–MS/MS method, Analytica Chimica Acta, 771, 65, 10.1016/j.aca.2013.02.004
Hammarlund-Udenaes, 2009, Methodologies to assess brain drug delivery in lead optimization, Current Topics in Medicinal Chemistry, 9, 148, 10.2174/156802609787521607
Hows, 2004, High-performance liquid chromatography/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples, Journal of Neuroscience Methods, 138, 123, 10.1016/j.jneumeth.2004.03.021
Li, 2006, Microdialysis as a tool in local pharmacodynamics, Aaps Journal, 8, E222, 10.1007/BF02854892
Matuszewski, 2003, Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC–MS/MS, Analytical Chemistry, 75, 3019, 10.1021/ac020361s
Nirogi, 2013, A sensitive and selective quantification of catecholamine neurotransmitters in rat microdialysates by pre-column dansyl chloride derivatization using liquid chromatography-tandem mass spectrometry, Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 913, 41, 10.1016/j.jchromb.2012.09.034
Paxinos, 1998
Pierce, 2006, The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse?, Neuroscience and Biobehavioral Reviews, 30, 215, 10.1016/j.neubiorev.2005.04.016
Rook, 2006, Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: Review of the literature, Current Clinical Pharmacology, 1, 109, 10.2174/157488406775268219
Samaha, 2005, Why does the rapid delivery of drugs to the brain promote addiction?, Trends in Pharmacological Sciences, 26, 82, 10.1016/j.tips.2004.12.007
Stowe, 2011, Developing a vaccine against multiple psychoactive targets: A case study of heroin, Cns & Neurological Disorders-Drug Targets, 10, 865, 10.2174/187152711799219316
Syslova, 2011, Monitoring of dopamine and its metabolites in brain microdialysates: Method combining freeze-drying with liquid chromatography–tandem mass spectrometry, Journal of Chromatography A, 1218, 3382, 10.1016/j.chroma.2011.02.006
Vindenes, 2009, Different effects on dopamine release in nucleus accumbens in mice by the morphine metabolites morphine-6-glucuronide and morphine-3-glucuronide, Basic & Clinical Pharmacology & Toxicology, 105, 357, 10.1111/j.1742-7843.2009.00451.x
Volkow, 2007, Dopamine in drug abuse and addiction: Results of imaging studies and treatment implications, Archives of Neurology, 64, 1575, 10.1001/archneur.64.11.1575
Zetterstrom, 1983, In vivo measurement of dopamine and its metabolites by intracerebral dialysis: Changes after d-amphetamine, Journal of Neurochemistry, 41, 1769, 10.1111/j.1471-4159.1983.tb00893.x